rs121918521
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 10P and 2B.
The NM_005765.3(ATP6AP2):c.321C>T(p.Asp107Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_005765.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- ATP6AP2-related disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- congenital disorder of glycosylation, type IIrInheritance: AR, XL Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- syndromic X-linked intellectual disability Hedera typeInheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- X-linked parkinsonism-spasticity syndromeInheritance: XL, Unknown Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 28
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Syndromic X-linked intellectual disability Hedera type Pathogenic:3
- -
Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. This sequence change affects codon 107 of the ATP6AP2 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the ATP6AP2 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with clinical features of ATP6AP2-related conditions (PMID: 15746149). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 10801). Experimental studies have shown that this variant affects ATP6AP2 function (PMID: 15746149). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. For these reasons, this variant has been classified as Pathogenic. -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Synonymous variant Functional studies provide moderate evidence of the variant having a damaging effect on the gene or gene product (PMID: 15746149). The variant has been reported to co-segregate with the disease in at least 7 similarly affected relatives/individuals in at least two unrelated families (PMID: 15746149). The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000010801 / PMID: 15746149). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at